VAN CHARLDORP, KARIN JULIETTE,BOSMAN, BRIGITTE JOHANNA FANNY,KLAVER, MONIQUE MARIA ALIDA,GARCIA HERNANDEZ, ALBERTO,DROGENDIJK, TENNIS EDWIN
申请号：
CA2741721
公开号：
CA2741721C
申请日:
2009.11.04
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The combined use of (R)-5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzene-1-sulfonamide(tamsulosin), or its pharmaceutically acceptable salt, and (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid (3R)-quinuclidin-3-yl ester (solifenacin), or its pharmaceutically acceptable salt,for the preparation of a medicament for the improvementof lower urinary tract symptoms associated with benign prostatic hyperplasia(LUTS/BPH) with a substantial storage componentis provided.
